Business Wire02.22.18
Endologix Inc., a developer and marketer of treatments for aortic disorders, announced that John McDermott is stepping down as the company’s CEO. To facilitate a smooth transition, McDermott has committed to remaining in his current role until a successor is found.
Daniel T. Lemaitre, Chairman of the Board of Endologix, said, “On behalf of the Board of Directors and the entire Endologix team, I would like to thank John for his remarkable passion and dedication to our Company. His leadership has been critical in positioning Endologix as an innovative market leader and in bringing novel solutions to doctors and patients across the globe. We appreciate John’s continued involvement and support of the company, and we wish him well in his future endeavors.”
John McDermott, CEO of Endologix, said, “Despite the business challenges over the past couple of years, I am confident that Endologix has a bright future. Our vision is clear, the value proposition is compelling, and our pipeline of new products positions us for significant long-term growth. I remain deeply committed to our employees, physicians, and patients and will do whatever I can to support an effective leadership transition.”
Daniel T. Lemaitre, Chairman of the Board of Endologix, said, “On behalf of the Board of Directors and the entire Endologix team, I would like to thank John for his remarkable passion and dedication to our Company. His leadership has been critical in positioning Endologix as an innovative market leader and in bringing novel solutions to doctors and patients across the globe. We appreciate John’s continued involvement and support of the company, and we wish him well in his future endeavors.”
John McDermott, CEO of Endologix, said, “Despite the business challenges over the past couple of years, I am confident that Endologix has a bright future. Our vision is clear, the value proposition is compelling, and our pipeline of new products positions us for significant long-term growth. I remain deeply committed to our employees, physicians, and patients and will do whatever I can to support an effective leadership transition.”